feedback welcome

Dosulepine-amitriptyline

From Psychiatrynet

(Difference between revisions)
Jump to:navigation, search
[draft revision][draft revision]
(Created page with '{{Drugswitch | from = dosulepine | to = amitriptyline | stop = * Gradually reduce dosage of clomipramine to a maximum of 50 mg/day. * When a dosage of 50 mg/day is reached, ...')
Line 3: Line 3:
| to = amitriptyline  
| to = amitriptyline  
| stop =  
| stop =  
-
* Gradually reduce dosage of clomipramine to a maximum of 50 mg/day.  
+
* Gradually reduce dosage of dosulepine to a maximum of 50 mg/day.  
* When a dosage of 50 mg/day is reached, stop administration.
* When a dosage of 50 mg/day is reached, stop administration.
| start =  
| start =  
* No wash-out period is needed.  
* No wash-out period is needed.  
* Start administration of amitriptyline the next day in a normal dosage of 50-100 mg/day.}}
* Start administration of amitriptyline the next day in a normal dosage of 50-100 mg/day.}}

Revision as of 10:10, 5 June 2009

dosulepin
Type antidepressant
Group TCA
links
ATC-code N06AA16
PubChem 13473
PubMed dosulepin
Kompas (Dutch) dosulepin
Wikipedia dosulepin
Amitriptyline
Type Antidepressant
Group TCA
links
ATC-code N06AA09
Medscape Amitriptyline
PubChem 2160
PubMed Amitriptyline
Kompas (Dutch) Amitriptyline
Wikipedia Amitriptyline

Switch medication from dosulepine to amitriptyline.

Nietinrijdenbord.png Stop dosulepine
Eenrichtingbord.png Start amitriptyline


The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.
Navigation
About